Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

AstraZeneca

Status: Completed

Conditions: Prostate Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT00540059

Zx-002

Details and patient eligibility

About

Purpose of this study is the evaluation of QoL, tolerability and use of Zoladex 10,8 SafeSystem for advanced PCa under naturalistic conditions

Enrollment: 1,950 patients

Sex: Male

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with PCa, who will be treated with Zoladex 10,8 SafeSystem based on the current SPC